4.5-STAR CMS RATING

Our Navitus MedicareRx Employer Group Waiver Plan (EGWP) has received a 4.5 out of 5 Overall Star Rating from the Centers for Medicare & Medicaid Services (CMS). This rating applies to plan year 2020.

On January 10, 2020

Taro Pharmaceuticals U.S.A., Inc. (“Taro” or the “Company”) is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 count bottles, NDC 51672-4131-1 to the consumer level.

about this drug recall >
On December 17, 2019

Glenmark Pharmaceutical Inc., USA (“Glenmark”) announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, to the consumer level.

 

about this drug recall >
On November 15, 2019

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Ranitidine Hydrochloride 150mg and 300mg Capsules (Manufactured by Novitium Pharma LLC)

about this drug recall >

 

This plan, Navitus MedicareRx (PDP), is offered by Navitus Health Solutions and underwritten by Dean Health Insurance, Inc., A Federally-Qualified Medicare Contracting Prescription Drug Plan.